Revenue Summary of Medical Developments International Limited

Medical Developments International Limited's latest annual revenue in 2024 was 33.14 Million AUD , up 2.51% from previous year.
Medical Developments International Limited's latest quarterly revenue in 2024 FY was 33.14 Million AUD , up 2.51% from previous quarter.
Medical Developments International Limited reported a annual revenue of 32.33 Million AUD in annual revenue 2023, up 47.37% from previous year.
Medical Developments International Limited reported a annual revenue of 21.94 Million AUD in annual revenue 2022, down -13.17% from previous year.
Medical Developments International Limited reported a quarterly revenue of 33.14 Million AUD for 2024 FY, up 2.51% from previous quarter.
Medical Developments International Limited reported a quarterly revenue of 15.08 Million AUD for 2024 Q2, down 0.0% from previous quarter.

Annual Revenue Chart of Medical Developments International Limited (2024 - 2003)

Historical Annual Revenue of Medical Developments International Limited (2024 - 2003)

Year	Revenue	Revenue Growth
2024	33.14 Million AUD	2.51%
2023	32.33 Million AUD	47.37%
2022	21.94 Million AUD	-13.17%
2021	25.27 Million AUD	12.15%
2020	22.53 Million AUD	7.95%
2019	20.87 Million AUD	19.56%
2018	17.46 Million AUD	-4.83%
2017	18.34 Million AUD	18.59%
2016	15.47 Million AUD	33.28%
2015	11.6 Million AUD	23.88%
2014	9.37 Million AUD	-20.14%
2013	11.73 Million AUD	3.71%
2012	11.31 Million AUD	10.85%
2011	10.2 Million AUD	23.02%
2010	8.29 Million AUD	-4.94%
2009	8.72 Million AUD	-5.34%
2008	9.21 Million AUD	24.65%
2007	7.39 Million AUD	11.98%
2006	6.6 Million AUD	22.22%
2005	5.4 Million AUD	77.3%
2004	3.04 Million AUD	-44.33%
2003	5.47 Million AUD	0.0%

Year	Revenue	Revenue Growth
2024 Q4	18.06 Million AUD	0.0%
2024 FY	33.14 Million AUD	2.51%
2024 Q2	15.08 Million AUD	0.0%
2023 Q2	13.92 Million AUD	0.0%
2023 FY	32.33 Million AUD	47.37%
2023 Q4	18.41 Million AUD	0.0%
2022 Q2	9.59 Million AUD	0.0%
2022 FY	21.94 Million AUD	-13.17%
2022 Q4	12.77 Million AUD	0.0%
2021 FY	25.27 Million AUD	12.15%
2021 Q4	12.69 Million AUD	0.0%
2021 Q2	12.57 Million AUD	0.0%
2020 FY	22.53 Million AUD	7.95%
2020 Q4	11.64 Million AUD	0.0%
2020 Q2	10.89 Million AUD	0.0%
2019 Q2	9.52 Million AUD	0.0%
2019 FY	20.87 Million AUD	19.56%
2019 Q4	11.35 Million AUD	0.0%
2018 Q2	7.8 Million AUD	0.0%
2018 FY	17.46 Million AUD	-4.83%
2018 Q4	9.65 Million AUD	0.0%
2017 FY	18.34 Million AUD	18.59%
2017 Q4	10.29 Million AUD	0.0%
2017 Q2	8.05 Million AUD	0.0%
2016 Q4	9.48 Million AUD	0.0%
2016 FY	15.47 Million AUD	33.28%
2016 Q2	5.99 Million AUD	0.0%
2015 Q4	6.1 Million AUD	0.0%
2015 Q2	5.5 Million AUD	0.0%
2015 FY	11.6 Million AUD	23.88%
2014 Q2	4.53 Million AUD	0.0%
2014 Q4	4.83 Million AUD	0.0%
2014 FY	9.37 Million AUD	-20.14%
2013 Q2	6.48 Million AUD	0.0%
2013 FY	11.73 Million AUD	3.71%
2013 Q4	5.25 Million AUD	0.0%
2012 Q3	2.82 Million AUD	0.0%
2012 Q1	2.55 Million AUD	0.0%
2012 Q4	2.82 Million AUD	0.0%
2012 FY	11.31 Million AUD	10.85%
2012 Q2	2.82 Million AUD	10.85%
2011 Q4	2.55 Million AUD	0.0%
2011 FY	10.2 Million AUD	23.02%
2011 Q2	2.55 Million AUD	23.02%
2011 Q3	2.55 Million AUD	0.0%
2011 Q1	2.07 Million AUD	0.0%
2010 FY	8.29 Million AUD	-4.94%
2010 Q1	2.18 Million AUD	0.0%
2010 Q2	2.07 Million AUD	-4.94%
2010 Q3	2.07 Million AUD	0.0%
2010 Q4	2.07 Million AUD	0.0%
2009 Q1	2.3 Million AUD	0.0%
2009 Q4	2.18 Million AUD	0.0%
2009 Q2	2.18 Million AUD	-5.34%
2009 Q3	2.18 Million AUD	0.0%
2009 FY	8.72 Million AUD	-5.34%
2008 Q3	2.3 Million AUD	0.0%
2008 Q4	2.3 Million AUD	0.0%
2008 Q2	2.3 Million AUD	23.58%
2008 Q1	1.86 Million AUD	0.0%
2008 FY	9.21 Million AUD	24.65%
2007 Q1	1.65 Million AUD	0.0%
2007 FY	7.39 Million AUD	11.98%
2007 Q4	1.86 Million AUD	0.0%
2007 Q3	1.86 Million AUD	0.0%
2007 Q2	1.86 Million AUD	12.94%
2006 Q2	1.65 Million AUD	22.22%
2006 Q1	1.35 Million AUD	0.0%
2006 Q3	1.65 Million AUD	0.0%
2006 Q4	1.65 Million AUD	0.0%
2006 FY	6.6 Million AUD	22.22%
2005 Q4	1.35 Million AUD	0.0%
2005 Q3	1.35 Million AUD	0.0%
2005 FY	5.4 Million AUD	77.3%
2005 Q2	1.35 Million AUD	77.3%
2005 Q1	762 Thousand AUD	0.0%
2004 Q1	1.36 Million AUD	0.0%
2004 FY	3.04 Million AUD	-44.33%
2004 Q2	762 Thousand AUD	-44.33%
2004 Q3	762 Thousand AUD	0.0%
2004 Q4	762 Thousand AUD	0.0%
2003 Q2	1.36 Million AUD	0.0%
2003 FY	5.47 Million AUD	0.0%
2003 Q3	1.36 Million AUD	0.0%
2003 Q4	1.36 Million AUD	0.0%

Peer Revenue Comparison of Medical Developments International Limited

Name	Revenue	Revenue Difference
Althea Group Holdings Limited	29.4 Million AUD	-12.748%
Cann Group Limited	15.37 Million AUD	-115.631%
ECS Botanics Holdings Ltd	20.03 Million AUD	-65.494%
Ecofibre Limited	27.98 Million AUD	-18.457%
Elixinol Wellness Limited	8.26 Million AUD	-300.883%
Hygrovest Limited	260 Thousand AUD	-12649.615%
IDT Australia Limited	13.22 Million AUD	-150.635%
Invion Limited	3.69 Million AUD	-797.312%
Little Green Pharma Ltd	19.56 Million AUD	-69.405%
Live Verdure Ltd	1.93 Million AUD	-1612.229%
Vitura Health Limited	123.87 Million AUD	73.239%
Vita Life Sciences Limited	74.16 Million AUD	55.301%

Global Stocks Search

Medical Developments International Limited (MVP.AX)

Revenue Summary of Medical Developments International Limited

Annual Revenue Chart of Medical Developments International Limited (2024 - 2003)

Historical Annual Revenue of Medical Developments International Limited (2024 - 2003)

Peer Revenue Comparison of Medical Developments International Limited